Cargando…

Distinct Mechanisms of IgM Antibody-Mediated Acquired von Willebrand Syndrome and Successful Treatment with Recombinant von Willebrand Factor in One Patient

Acquired von Willebrand Syndrome (AVWS) is a rare coagulation disorder which can be associated with IgM paraproteinaemia. Recently, recombinant von Willebrand factor (rVWF) has become available for the treatment of bleedings in patients with inherited von Willebrand disease, but experience in patien...

Descripción completa

Detalles Bibliográficos
Autores principales: Höpting, Matthias, Budde, Ulrich, Tiede, Andreas, Grube, Matthias, Hahn, Joachim, Herr, Wolfgang, Heimerl, Susanne, Hart, Christina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9501758/
https://www.ncbi.nlm.nih.gov/pubmed/35086107
http://dx.doi.org/10.1159/000522236
_version_ 1784795549178789888
author Höpting, Matthias
Budde, Ulrich
Tiede, Andreas
Grube, Matthias
Hahn, Joachim
Herr, Wolfgang
Heimerl, Susanne
Hart, Christina
author_facet Höpting, Matthias
Budde, Ulrich
Tiede, Andreas
Grube, Matthias
Hahn, Joachim
Herr, Wolfgang
Heimerl, Susanne
Hart, Christina
author_sort Höpting, Matthias
collection PubMed
description Acquired von Willebrand Syndrome (AVWS) is a rare coagulation disorder which can be associated with IgM paraproteinaemia. Recently, recombinant von Willebrand factor (rVWF) has become available for the treatment of bleedings in patients with inherited von Willebrand disease, but experience in patients with AVWS is limited. We report on 2 patients with AVWS with underlying IgM paraproteinaemia with distinct underlying pathomechanisms. In 1 patient, the paraprotein built unspecific complexes with von Willebrand factor (VWF). In the other patient, we were able to detect an IgM antibody against VWF. Bleeding in this patient was successfully treated with rVWF. To our knowledge, this is the first report about the successful use of rVWF in a patient with AVWS with the detection of a VWF-specific antibody.
format Online
Article
Text
id pubmed-9501758
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher S. Karger AG
record_format MEDLINE/PubMed
spelling pubmed-95017582022-09-24 Distinct Mechanisms of IgM Antibody-Mediated Acquired von Willebrand Syndrome and Successful Treatment with Recombinant von Willebrand Factor in One Patient Höpting, Matthias Budde, Ulrich Tiede, Andreas Grube, Matthias Hahn, Joachim Herr, Wolfgang Heimerl, Susanne Hart, Christina Acta Haematol Case Report Acquired von Willebrand Syndrome (AVWS) is a rare coagulation disorder which can be associated with IgM paraproteinaemia. Recently, recombinant von Willebrand factor (rVWF) has become available for the treatment of bleedings in patients with inherited von Willebrand disease, but experience in patients with AVWS is limited. We report on 2 patients with AVWS with underlying IgM paraproteinaemia with distinct underlying pathomechanisms. In 1 patient, the paraprotein built unspecific complexes with von Willebrand factor (VWF). In the other patient, we were able to detect an IgM antibody against VWF. Bleeding in this patient was successfully treated with rVWF. To our knowledge, this is the first report about the successful use of rVWF in a patient with AVWS with the detection of a VWF-specific antibody. S. Karger AG 2022-07 2022-01-27 /pmc/articles/PMC9501758/ /pubmed/35086107 http://dx.doi.org/10.1159/000522236 Text en Copyright © 2022 by The Author(s). Published by S. Karger AG, Basel https://creativecommons.org/licenses/by/4.0/This article is licensed under the Creative Commons Attribution 4.0 International License (CC BY). Usage, derivative works and distribution are permitted provided that proper credit is given to the author and the original publisher. Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug. Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
spellingShingle Case Report
Höpting, Matthias
Budde, Ulrich
Tiede, Andreas
Grube, Matthias
Hahn, Joachim
Herr, Wolfgang
Heimerl, Susanne
Hart, Christina
Distinct Mechanisms of IgM Antibody-Mediated Acquired von Willebrand Syndrome and Successful Treatment with Recombinant von Willebrand Factor in One Patient
title Distinct Mechanisms of IgM Antibody-Mediated Acquired von Willebrand Syndrome and Successful Treatment with Recombinant von Willebrand Factor in One Patient
title_full Distinct Mechanisms of IgM Antibody-Mediated Acquired von Willebrand Syndrome and Successful Treatment with Recombinant von Willebrand Factor in One Patient
title_fullStr Distinct Mechanisms of IgM Antibody-Mediated Acquired von Willebrand Syndrome and Successful Treatment with Recombinant von Willebrand Factor in One Patient
title_full_unstemmed Distinct Mechanisms of IgM Antibody-Mediated Acquired von Willebrand Syndrome and Successful Treatment with Recombinant von Willebrand Factor in One Patient
title_short Distinct Mechanisms of IgM Antibody-Mediated Acquired von Willebrand Syndrome and Successful Treatment with Recombinant von Willebrand Factor in One Patient
title_sort distinct mechanisms of igm antibody-mediated acquired von willebrand syndrome and successful treatment with recombinant von willebrand factor in one patient
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9501758/
https://www.ncbi.nlm.nih.gov/pubmed/35086107
http://dx.doi.org/10.1159/000522236
work_keys_str_mv AT hoptingmatthias distinctmechanismsofigmantibodymediatedacquiredvonwillebrandsyndromeandsuccessfultreatmentwithrecombinantvonwillebrandfactorinonepatient
AT buddeulrich distinctmechanismsofigmantibodymediatedacquiredvonwillebrandsyndromeandsuccessfultreatmentwithrecombinantvonwillebrandfactorinonepatient
AT tiedeandreas distinctmechanismsofigmantibodymediatedacquiredvonwillebrandsyndromeandsuccessfultreatmentwithrecombinantvonwillebrandfactorinonepatient
AT grubematthias distinctmechanismsofigmantibodymediatedacquiredvonwillebrandsyndromeandsuccessfultreatmentwithrecombinantvonwillebrandfactorinonepatient
AT hahnjoachim distinctmechanismsofigmantibodymediatedacquiredvonwillebrandsyndromeandsuccessfultreatmentwithrecombinantvonwillebrandfactorinonepatient
AT herrwolfgang distinctmechanismsofigmantibodymediatedacquiredvonwillebrandsyndromeandsuccessfultreatmentwithrecombinantvonwillebrandfactorinonepatient
AT heimerlsusanne distinctmechanismsofigmantibodymediatedacquiredvonwillebrandsyndromeandsuccessfultreatmentwithrecombinantvonwillebrandfactorinonepatient
AT hartchristina distinctmechanismsofigmantibodymediatedacquiredvonwillebrandsyndromeandsuccessfultreatmentwithrecombinantvonwillebrandfactorinonepatient